Guildford, UK, 24 June 2011: ReNeuron announces that it is launching a newly designed corporate website. The website has enhanced layout and content, reflecting the Company’s progress, ambition and leading position in the development of novel stem cell therapeutics for stroke and other significant disease conditions.
The new website will go live over this coming weekend, the precise timing from the user’s perspective being subject to some variation depending on the user’s internet service provider. Subscribers to the Company’s email alert service are requested to re-subscribe on the new website to ensure continuing provision of email press release alerts.
There is no change to the Company’s website address, which remains as https://www.reneuron.com